-
2024-511538-11-00
4
2023-02-07
Non resectable Hepatocellular carcinoma (HCC)
-
2023-503793-20-00
5
2023-01-18
Prevention of ischemic stroke in patients post acute non-cardioembolic
-
2023-504239-41-00
5
2023-01-09
Hepatitis B, Chronic
-
2023-508528-36-00
5
2022-12-16
Resected squamous cell carcinoma of the head and neck
-
2022-501029-19-00
6
2022-12-13
Asthma
-
2023-506369-79-00
4
2022-11-30
Pancreatic ductal adenocarcinoma
-
2024-516711-24-00
7
2022-10-18
Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC)
-
2024-515196-35-00
3
2022-09-29
Platinum-Resistant Ovarian Cance
-
2022-500363-12-00
4
2022-08-24
SARS CoV-2 (COVID-19)
-
2023-503797-21-00
5
2022-08-10
Metastatic Colorectal Cancer
-
2023-509569-19-00
10
2022-08-10
venous thromboembolism (VTE)
-
2024-511069-12-00
5
2022-07-28
Sjögren’s Syndrome
-
2024-513653-75-00
5
2022-05-30
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called
-
2023-506981-30-00
4
2022-05-25
Chronic kidney disease in type 2 diabetes mellitus
-
2024-514419-93-00
9
2022-05-19
Study to investigate the safety and efficacy of GB1211 (a galectin-3 i
-
2024-511996-13-00
5
2022-05-11
Previously untreated, unresectable, or metastatic melanoma
-
2022-502802-34-00
5
2022-04-05
Dravet and Lennox-Gastaut Syndromes
-
2024-510696-38-00
5
2022-03-08
Severe Hypertriglyceridemia.
-
2023-506511-17-00
4
2022-03-07
Binge eating disorder
-
2023-503572-24-00
5
2022-03-02
Chronic Obstructive Pulmonary Disease (COPD)
-
2024-516021-32-00
5
2022-02-17
Critically ill patients suffering from CIRCI
-
2024-515039-31-00
4
2022-02-10
Isatuximab in type I cryoglobulinaemia: A prospective pilot study
-
2023-506589-30-00
5
2022-02-09
Invasive Extraintestinal Pathogenic Escherichia coli Disease
-
2024-513707-14-00
5
2022-01-14
Only patients with oncologic locally advanced or metastatic tumour (lu